NCT00013884View on ClinicalTrials.gov

HIV Maintenance Therapy With T-20 During HAART Interruption

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

April 30, 2003

Conditions
HIV Infection
Interventions
DRUG

T-20

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00013884 - HIV Maintenance Therapy With T-20 During HAART Interruption | Biotech Hunter | Biotech Hunter